1998
Epidemiology of acute respiratory infections
Shapiro E. Epidemiology of acute respiratory infections. Seminars In Pediatric Infectious Diseases 1998, 9: 31-36. DOI: 10.1016/s1045-1870(98)80048-4.Peer-Reviewed Original ResearchAcute respiratory infectionsYears of ageRespiratory infectionsAnnual mortality rateMortality rateFrequency of ARICase fatality rateMethods of surveillanceCounter medicationsOutpatient settingSerious infectionsChildren 1New vaccinesImportant causeInfectionYoung childrenInfantsChildrenAgeMost studiesAnnual costYearsMedicationsVaccineEpidemiology
1994
Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1
Andiman W, Mezger J, Shapiro E. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1. The Journal Of Pediatrics 1994, 124: 846-852. PMID: 8201465, DOI: 10.1016/s0022-3476(05)83169-5.Peer-Reviewed Original ResearchConceptsInvasive bacterial infectionsHuman immunodeficiency virus type 1Immunodeficiency virus type 1Years of ageVirus type 1Bacterial infectionsHIV-1 infection statusHIV-1-infected mothersHIV-1-infected patientsType 1Instances of bacteremiaSerious focal infectionsObservational cohort studyRate of infectionMonths of ageUninfected subjectsCohort studyPneumococcal bacteremiaInvasive infectionsFocal infectionHIV-1Cerebrospinal fluidS. pneumoniaeHIVStreptococcus pneumoniae
1990
Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
Shapiro E, Berg A. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine. Pediatrics 1990, 85: 643-7. PMID: 2179854, DOI: 10.1542/peds.85.4.643.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsType b polysaccharide vaccineH influenzae type b polysaccharide vaccineHaemophilus influenzae type b polysaccharide vaccinePolysaccharide vaccineProtective efficacyMonths of ageVaccine failureInvasive diseaseH influenzae type b.Immunization Practices Advisory CommitteeH influenzae type bVaccine protective efficacyRandomized clinical trialsInfluenzae type bAvailable epidemiologic dataNormal serum concentrationsYears of ageTotal immunoglobulinSerum concentrationsImmune deficiencyClinical trialsEpidemiologic dataHemolytic complementVaccineChildren 18